Insights

Takeaways from MIT Sloan 2025 AI Conference:
“Age of Implementation”

Members of Choate’s Patent and IP team attended the MIT Sloan 2025 AI Conference, themed “Age of Implementation," at the MIT Media Lab on February 7 and compiled their key takeaways.

FDA Issues Draft Guidance Regarding AI Models Used in Support of Regulatory Decisions Highlighting Changing Risks and Opportunities for IP Strategy

In early January 2025, FDA issued draft guidance titled, Considerations for the Use of Artificial Intelligence to Support Regulatory Decision Making for Drug and Biological Products (“Draft Guidance”), regarding the use of artificial intelligence (AI) to support FDA decision-making in the drug product lifecycle.

Universal DX (UDX) Closes Series B Funding for Clinical Trials on Colorectal Cancer Screening Blood Test, Signal-C®

Choate represented Universal DX (UDX) in IP diligence for its Series B funding round, which will advance the clinical trial of Signal-C, UDX’s colorectal cancer screening blood test, which is on track to enroll 15,000 patients across 100 sites.

Choate Receives High Rankings from Managing IP 2024

Managing IP’s 2024 rankings of firms for patent litigation and protection work recognizes eight attorneys and Choate regionally and nationally for its work in the areas of patent prosecution and patent disputes.

The White House Issues Executive Order on AI

On October 30, 2023, President Biden issued an Executive Order (EO) that directs the National Institute of Standards and Technology (NIST) to develop standards for red-team testing of AI models, that is, adversarial testing for software risks and vulnerabilities.

Choate Receives High Rankings for Patent Work from Managing IP 2023

Managing IP’s 2023 rankings of firms for patent litigation and protection work recognizes seven attorneys and Choate regionally and nationally for its work in the areas of patent prosecution, patent disputes and life sciences.

Managing IP Names Seven Choate Attorneys "IP Stars"

Managing IP recognizes seven Choate attorneys – Michael S. Bunis, Robert S. Frank Jr., Dr. William R. Haulbrook, Dr. Brenda Herschbach Jarrell, Dr. Charles Lyon, Eric J. Marandett, Dr. Rolando Medina – in its 2022 guide of “IP Stars.”

Immuneering Corporation Goes Public with $112M IPO

Choate assisted Immuneering Corporation with handling its platform IP in its $112.5M IPO. A portion of the proceeds from the IPO will be used to bring Immuneering’s lead candidate, a dual-MEK inhibitor dubbed IMM-1-104, into the clinic for advanced solid tumors in patients harboring RAS mutations.

Choate Partners Ranked as IP Stars by Managing IP

Managing IP recently recognized six Choate partners - Robert S. Frank Jr., Dr. William R. Haulbrook, Dr. Brenda Herschbach Jarrell, Dr. Charles Lyon, Eric J. Marandett, and Dr. Rolando Medina – in its 2021 guide of “IP Stars.”